The Study of Safety and Preliminary Efficacy of ALT001 in Patients With MultIple System Atrophy-Cerebellar Type
NCT07514923
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Multiple System Atrophy - Cerebellar Subtype (MSA-C)
Interventions
DRUG:
ALT001
Sponsor
yilong Wang